What mechanisms link purinergic signaling to coagulation pathways in COVID-19 neurological complications?

OPEN

The study shows correlations between ATP/ADP and fibrinogen/coagulation proteins, but the mechanistic pathways connecting purinergic signaling to coagulopathy remain unexplained. This gap is critical since COVID-19 causes significant neurological complications including stroke and encephalitis. Gap type: unexplained_observation Source paper: Purinergic signaling elements are correlated with coagulation players in peripheral blood and leukocyte samples from COVID-19 patients. (2022, J Mol Med (Berl), PMID:35091759)

Priority: 0.79 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What mechanisms link purinergic signaling to coagulation pathways in COVID-19 neurological complications? is a 0.79 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What mechanisms link purinergic signaling to coagulation pathways in COVID-19 neurological complications? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

associated with (1)

InosineCOVID-19

biomarker for (1)

InosineCOVID-19

causes (3)

Sars-Cov-2COVID-19COVID-19CoagulopathyCOVID-19Blood-Brain Barrier Disruption

risk factor for (1)

NLRP3COVID-19

shares differentially expressed genes with (1)

36626425COVID-19

upregulated in (2)

P2RX1COVID-19P2RX4COVID-19

upregulates (3)

P2RX1COVID-19P2RX7COVID-19NLRP3COVID-19
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps